Table 1 Patient characteristics
Characteristics | No. | % |
|---|---|---|
Sex | ||
Male | 115 | 82.7 |
Female | 24 | 17.3 |
Histological grading | ||
G1 | 12 | 8.6 |
G2 | 61 | 43.9 |
G3/4 | 38 | 27.3 |
Gx | 28 | 20.1 |
Tumor site | ||
Proximal | 54 | 38.8 |
Medial | 75 | 54.0 |
Distal | 10 | 7.2 |
Tumor legngth | ||
≤ 5 cm | 65 | 46.8 |
> 5 cm | 74 | 53.2 |
T stage | ||
T1/2 | 17 | 12.2 |
T3 | 68 | 48.9 |
T4 | 54 | 38.8 |
M stage | ||
M1a | 54 | 38.8 |
M1b | 85 | 61.2 |
Laterality | ||
Unilateral CLNM | 106 | 76.2 |
Bilateral CLNM | 33 | 23.7 |
RT dose | ||
< 60 Gy | 45 | 32.4 |
≥ 60Gy | 94 | 67.6 |
Chemotherapy mode | ||
Induced CT+RCT | 29 | 20.9 |
RCT | 110 | 79.1 |
Concurrent chemotherapy | ||
Cisplatin+5-Fu | 44 | 31.7 |
Cisplatin+ docetaxel | 72 | 51.8 |
Other | 23 | 16.5 |
Response to treatment | ||
CR | 48 | 34.5 |
Non-CR | 91 | 65.5 |